Results 91 to 100 of about 3,132,176 (310)
This review systematically elaborates on the mechanisms underlying physiological regulation and pathological dysregulation of biomolecular phase separation. It also summarizes advances in phase‑separation‑targeted therapeutic strategies and the design of functional biomaterials inspired by this process.
Jiawei Zhu +5 more
wiley +1 more source
A living multi‐omics sarcoma PDX biobank is enriched for high‐risk disease and preserves key patient tumor features at histopathological and molecular levels. Integrated profiling reveals ecDNA‐driven oncogene amplification in osteosarcoma and preferential retention of ecDNA during PDX evolution.
Weisong Zhao +34 more
wiley +1 more source
Chronic radiation-induced dermatitis: what is new in 2024? A narrative review
Radiation exposure can cause two main types of dermatitis: acute radiation dermatitis (ARD) and chronic radiation dermatitis (CRD). ARD appears days to weeks after exposure, with symptoms including redness, peeling, and blistering.
Eryk Siedlecki +2 more
doaj +1 more source
PI3K inhibition enhances doxorubicin-induced apoptosis in sarcoma cells [PDF]
We searched for a drug capable of sensitization of sarcoma cells to doxorubicin (DOX). We report that the dual PI3K/mTOR inhibitor PI103 enhances the efficacy of DOX in several sarcoma cell lines and interacts with DOX in the induction of apoptosis ...
Dittmann, Kai +49 more
core +1 more source
Concurrent Germline RB1 & Mosaic TP53 in a Child With Multiple Childhood Cancers
ABSTRACT We report a patient with a pathogenic germline variant (PGV) in RB1 and somatic mosaicism for a pathogenic TP53 variant who developed three distinct types of childhood cancer: retinoblastoma, osteosarcoma, and myelodysplastic syndrome (MDS) before the age of 6 years.
Ole Haubjerg Nielsen +8 more
wiley +1 more source
Aims This study looks at the status of the same drugs conditionally approved by the Food and Drug Administration and Health Canada for the same oncology indication. Methods Lists of oncology drugs with a conditional approval from the Food and Drug Administration and Health Canada were generated and drug pairs with the same indication were matched ...
Joel Lexchin
wiley +1 more source
Chondrosarcoma: from genomics to clinical trials
Chondrosarcoma (CS) is a rare and heterogeneous group of malignant cartilaginous tumors characterizedby variation in histological subtype, molecular profile, clinical behavior, prognosis, and treatment response.Conventional CS constitutes the majority of
Mritunjoy Dey +4 more
doaj +1 more source
The introduction of immunotherapy with checkpoint inhibitors into clinical practice has radically changed the treatment and prognosis of patients with cancer.
Hanna Koseła-Paterczyk
doaj +1 more source
Carbon ion radiotherapy for unresectable localized axial soft tissue sarcoma
Carbon ion radiotherapy is known for its high‐precision dose distribution and high biological effectiveness. We evaluated the results of carbon ion radiotherapy in 128 patients with unresectable localized axial soft tissue sarcoma at a single institution.
Tadashi Kamada +3 more
core +1 more source
This review systematically summarizes the major molecular mechanisms governing TAM polarization and their coordinated interactions. It further highlights recent advances in nanoagonist‐based strategies that intervene in these pathways to reprogram TAMs, critically discussing their therapeutic potential, current limitations, and translational prospects.
Siqi Fang +7 more
wiley +1 more source

